Masayuki Ueno

18PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersHaematological tumoursGastroenterology and hepatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 03, 2026
Reply to "Performance of risk models in predicting outcomes of atezolizumab and bevacizumab therapy".

Masayuki Ueno, Atsushi Takai, Hiroshi Seno

|Oct 14, 2025
Tamoxifen-Induced Liver Injury in Patients With Breast Cancer: Frequency, Risk Factors and Clinical Course.

Ayako Ueno, Masayuki Ueno, Mayo Nishikawa

|Sep 13, 2025
Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective Study.

Masayuki Ueno, Haruhiko Takeda, Atsushi Takai

|Jun 25, 2025
Acquisition Process and Clinical Relevance of dMMR-Associated Mutational Signatures in Hepatocellular Carcinoma.

Masayuki Ueno, Haruhiko Takeda, Atsushi Takai

Pageof 3